MATERIALISE NV (MTLS)
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
Sector: Services-Prepackaged Software
Industry: Software - Application
Materialise N.V.
1-25 of 280 filings
Recent SEC filings with analysis
- 6-KMaterialise NV repurchased 184,068 shares between 26 and 30 October 2026 at an average price of 6.47 EUR, for a total of 1,191,668 EUR, all via the Nasdaq…
- 6-KMaterialise NV reported Q3 2026 revenue of 67,670 kEUR, up 2.1% year-over-year, driven by 9.7% growth in the Medical segment to 36,542 kEUR.
- 6-KMaterialise NV reported Q3 2026 revenue of EUR 67.7 million, up 2.1% year-over-year or 4.9% excluding revenue from recently divested RapidFit and Eyewear…
- 6-KMaterialise NV repurchased 50,211 shares for EUR 379,205 (average EUR 7.55/share) during the week of 19-23 October 2026 under its EUR 30 million buyback…
- 6-KMaterialise NV reported the repurchase of 106,794 shares for EUR 772,705 (average price EUR 7.24) during the week of 12-16 October 2026, all through the NASDAQ…
- 6-KMaterialise NV (MTLS) reported it repurchased 130,592 shares for EUR 975,791 in the week of 5-9 October 2026 at an average price of EUR 7.47 per share, all…
- 6-KMaterialise NV (Euronext/Nasdaq: MTLS) reported it repurchased 108,902 shares at an average price of EUR 7.54 for a total of EUR 821,459 during the week of 28…
- 6-KMaterialise NV reported the purchase of 31,306 shares at an average price of EUR 6.99 for a total of EUR 218,945 during the week of 21-25 September 2026, under…